¼¼°èÀÇ Çǵà¼È ¸¶Ä¿ ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Á¦Ç° À¯Çüº°, ¾ç½Äº°, ¾Ï À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2023-2030³â)
Global Fiducial Markers Market Size study & Forecast, by Product by Modality, by Cancer type, by End User and Regional Analysis, 2023-2030
»óǰÄÚµå
:
1300761
¸®¼Ä¡»ç
:
Bizwit Research & Consulting LLP
¹ßÇàÀÏ
:
2023³â 06¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
Çǵà¼È ¸¶Ä¿´Â ¹æ»ç¼± Ä¡·á¿¡¼ ¼ö¼ú ºÎÀ§¸¦ ½Äº°Çϰí Á¤È®ÇÑ ¹æ»ç¼±·®À» Á¶»çÇϱâ À§ÇØ »ç¿ëµÇ´Â µµ±¸ÀÔ´Ï´Ù.
Çǵà¼È ¸¶Ä¿´Â Á¾¾çÀÇ Á¤È®ÇÑ À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, ÀÇ»ç´Â ÁÖº¯ Á¶Á÷À» ¼Õ»ó½ÃŰÁö ¾Ê°í ȯÀÚ¿¡°Ô ÀûÀýÇÑ ¾çÀÇ ¹æ»ç¼±À» Á¶»çÇÒ ¼ö ÀÖ½À´Ï´Ù. Çǵà¼È ¸¶Ä¿´Â ±Ý¼Ó ±â¹Ý, Æú¸®¸Ó ±â¹Ý µî ´Ù¾çÇÑ ÇüÅ·ΠÁ¦°øµË´Ï´Ù. ¶ÇÇÑ, Çǵà¼È ¸¶Ä¿ ±â¼úÀº Çǵà¼ÈÀÇ 3D À̹ÌÁö¸¦ Á¦°øÇϰí, Á¤È®ÇÑ Áø´Ü°ú ±ÇÀå Ä¡·á¹ýÀ» ´ãÀº º¸°í¼¸¦ ÀÛ¼ºÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È Çǵà¼È ¸¶Ä¿ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÁÖ¿ä ¿äÀÎÀº ¾ÏÀÇ À¯º´·ü Áõ°¡¿Í ÀϰüµÈ »óȯ Á¤Ã¥ÀÔ´Ï´Ù. ¶ÇÇÑ, ¹æ»ç¼± Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Çǵà¼È ¸¶Ä¿ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
¶ÇÇÑ, ¾Ï À¯º´·ü Áõ°¡´Â Çǵà¼È ¸¶Ä¿ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Çǵà¼È ¸¶Ä¿´Â ¹æ»ç¼± Ä¡·á¿¡ »ç¿ëµÇ¸ç, ¾Ï Á¾¾çÀ» Á¤È®ÇÏ°Ô Á¶ÁØÇÏ¿© ¹æ»ç¼±À» Á¶»çÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ¾ÏÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¹æ»ç¼± Ä¡·á¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡ÇÏ¿© Çǵà¼È ¸¶Ä¿ÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ĵ¼ Åõ¸ð·Î¿ì(Cancer Tomorrow)¿¡ µû¸£¸é 2020³â Áß±¹ÀÇ ¾Ï ȯÀÚ ¼ö´Â ¾à 457¸¸ ¸íÀ̸ç, 2030³â¿¡´Â 581¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ¿¡ µû¶ó ¾Ï ȯÀÚ ¼ö Áõ°¡´Â ½ÃÀå ¼ºÀåÀÇ ±âȸ°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¾Ï ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ¿Í ÁöÃâÀÌ ±ÞÁõÇÏ¸é¼ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª, ³ôÀº ºñ¿ëÀ¸·Î ÀÎÇØ 2023³âºÎÅÍ 2030³â±îÁö ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
ÀÌ º¸°í¼¿¡¼ °í·ÁÇÑ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç, °£¼ÒÈµÈ »óȯ ±ÔÁ¤ ¹× °øÁß º¸°Ç ³ë·ÂÀ¸·Î ÀÎÇØ 2022³â ½ÃÀåÀ» Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ Ã·´Ü ¹æ»ç¼± ±â¼ú ¹× ¿µ»ó Áø´Ü ¾ç½ÄÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ Áö¿ªÀÇ Á¦Ç° ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ½ÃÀå È®ÀåÀ» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À̴ ƯÈ÷ Áß±¹°ú Àεµ¿¡¼ ¾Ï Ä¡·á ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡¿Í ÇÔ²² ÀÓ»ó ¹ÌÃæÁ· ¼ö¿ä°¡ ³ô±â ¶§¹®ÀÔ´Ï´Ù.
ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â Á¶»ç ´ë»ó ±¹°¡ »ê¾÷ÀÇ ÁúÀû/¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀå ÇöȲ
- ¼¼°è ½ÃÀ塤ºÎ¹®º° ½ÃÀå Ã߻ꡤ¿¹Ãø, 2020-2030³â
- ±âÁØ ¸¶Ä¿ ½ÃÀå : Áö¿ªº°, 2020-2030³â
- ±âÁØ ¸¶Ä¿ ½ÃÀå : Á¦Ç°º°, 2020-2030³â
- ±âÁØ ¸¶Ä¿ ½ÃÀå : ¸ð´Þ¸®Æ¼º°, 2020-2030³â
- ±âÁØ ¸¶Ä¿ ½ÃÀå : ¾Ï À¯Çüº°, 2020-2030³â
- ±âÁØ ¸¶Ä¿ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, 2020-2030³â
- ÁÖ¿ä µ¿Çâ
- Á¶»ç ¹æ¹ý
- Á¶»ç ÀüÁ¦Á¶°Ç
Á¦2Àå ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
- Á¶»ç ¸ñÀû
- ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
- Á¶»ç ´ë»ó³âµµ
- ÅëÈ È¯»êÀ²
Á¦3Àå ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå ¿ªÇÐ
- ±âÁØ ¸¶Ä¿ ½ÃÀå¿¡ ´ëÇÑ ¿µÇ⠺м®(2020-2030³â)
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
- ½ÃÀå ±âȸ
Á¦4Àå ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå »ê¾÷ ºÐ¼®
- Porter's Five Forces ¸ðµ¨
- °ø±Þ ±â¾÷ÀÇ ±³¼··Â
- ¹ÙÀ̾îÀÇ ±³¼··Â
- ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
- ´ëüǰÀÇ À§Çù
- °æÀï ±â¾÷°£ °æÀï °ü°è
- Porter's Five ForcesÀÇ ¿µÇ⠺м®
- PEST ºÐ¼®
- Á¤Ä¡
- °æÁ¦
- »çȸ
- 񃬣
- ȯ°æ
- ¹ý·ü
- ÁÖ¿ä ÅõÀÚ ±âȸ
- ÁÖ¿ä ¼º°ø Àü·«
- COVID-19ÀÇ ¿µÇ⠺м®
- ÆÄ±«Àû µ¿Çâ
- ¾÷°è Àü¹®°¡ÀÇ °ßÇØ
- ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È
Á¦5Àå ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå : Á¦Ç°º°
- ½ÃÀå ÇöȲ
- ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå : Á¦Ç°º°, ½ÇÀû-°¡´É¼º ºÐ¼®
- ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
- ±Ý¼Ó ±â¹Ý ¸¶Ä¿
- Æú¸®¸Ó ±â¹Ý ¸¶Ä¿
- ±âŸ ±âÁØ ¸¶Ä¿
Á¦6Àå ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå : ¸ð´Þ¸®Æ¼º°
- ½ÃÀå ÇöȲ
- ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå : ¸ð´Þ¸®Æ¼º°, ½ÇÀû-°¡´É¼º ºÐ¼®
- ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå : ¸ð´Þ¸®Æ¼º° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
- CT/CBCT
- MRI
- ¹æ»ç¼± ¿ä¹ý
- ÃÊÀ½ÆÄ
Á¦7Àå ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå : ¾Ï À¯Çüº°
- ½ÃÀå ÇöȲ
- ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå : ¾Ï À¯Çüº°, ½ÇÀû-°¡´É¼º ºÐ¼®
- ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå : ¾Ï À¯Çüº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
- Æó¾Ï
- À¯¹æ¾Ï
- À§¾Ï
- Àü¸³¼±¾Ï
- ±âŸ ¾Ï
Á¦8Àå ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°
- ½ÃÀå ÇöȲ
- ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ½ÇÀû-°¡´É¼º ºÐ¼®
- ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
- º´¿ø ¹× ¿Ü·¡ ȯÀÚ ½Ã¼³
- ¾Ï ¿¬±¸¼¾ÅÍ
- µ¶¸³°è ¹æ»ç¼± Ä¡·á ¼¾ÅÍ
Á¦9Àå ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå : Áö¿ªº° ºÐ¼®
- ÁÖ¿ä ±¹°¡
- ÁÖ¿ä ½ÅÈï ±¹°¡
- ¼¼°èÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
- ºÏ¹Ì
- ¹Ì±¹
- Á¦Ç° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ¸ð´Þ¸®Æ¼ ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ¾Ï À¯Çü ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ÃÖÁ¾»ç¿ëÀÚ ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ij³ª´Ù
- À¯·´ÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå ÇöȲ
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ½ºÆäÀÎ
- ÀÌÅ»¸®¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå ÇöȲ
- Áß±¹
- Àεµ
- ÀϺ»
- È£ÁÖ
- Çѱ¹
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ±âÁØ ¸¶Ä¿ ½ÃÀå ÇöȲ
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦10Àå °æÀï Á¤º¸
- ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
- ÁÖ¿ä ½ÃÀå Àü·«
- ±â¾÷ °³¿ä
- CIVCO Radiotherapy
- ÁÖ¿ä Á¤º¸
- °³¿ä
- À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì)
- Á¦Ç° °³¿ä
- ÃÖ±Ù µ¿Çâ
- IZI Medical Products
- Naslund Medical AB
- Medtronic PLC
- QlRad, Inc.
- QFIX
- Boston Scientific Corp.
- Nanovi A/S
- Eckert & Ziegler
- IBA Dosimetry GmbH
Á¦11Àå Á¶»ç °úÁ¤
- Á¶»ç °úÁ¤
- µ¥ÀÌÅÍ ¸¶ÀÌ´×
- ºÐ¼®
- ½ÃÀå ÃßÁ¤
- °ËÁõ
- ÃâÆÇ
- Á¶»ç ¼Ó¼º
- Á¶»ç ÀüÁ¦Á¶°Ç
LSH
¿µ¹® ¸ñÂ÷
Global Fiducial Markers Market is valued approximately at USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. A fiducial marker is a tool used in radiotherapy treatments to identify where surgery was performed and delivered precise radiation dose. The fiducial marker can pinpoint the exact location of the tumor and let the doctor give the patient the right amount of radiation without damaging surrounding tissue. Fiducial markers come in a variety of forms, including metal- and polymer-based markers, among others. The fiducial marker technology may also offer a 3D image of the fiducials and produce a report with a precise diagnosis and suggested treatment actions. Major factors that are expected to boost the growth of the Fiducial Markers market in the forecast period are the rise in the prevalence of cancer and the cohesive reimbursement policies. Furthermore, the increase in awareness on the radiotherapy is further propelling the growth of the Fiducial Markers market.
Moreover, the increase in cancer prevalence contributes to the growth of the Fiducial Markers Market. Fiducial markers are used in radiation therapy to precisely target and deliver radiation to cancerous tumors. As the prevalence of cancer increases, the demand for radiation therapy also rises, driving the need for fiducial markers. According to Cancer Tomorrow, in 2020, the number of cancer cases in China was around 4.57 million and the number is anticipated to reach 5.81 million by 2030. As a result, rising number of cancer cases is anticipated to create the lucrative opportunity for the market growth. Additionally, upsurge in the investments and spending for the cancer research is anticipated to create the lucrative opportunity for the market during forecast period. However, the high cost of Fiducial Markers stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Fiducial Markers Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, streamlined reimbursement rules, and public health initiatives. Additionally, the increasing use of advanced radiation techniques and imaging modalities will increase product demand in the area, boosting market expansion. Asia Pacific is expected to grow at fastest growth rate during the forecast period, owing to highly unmet clinical needs together with a rise of cancer care initiatives, particularly in China and India, are expected to boost the region's growth.
Major market players included in this report are:
- CIVCO Radiotherapy
- IZI Medical Products
- Naslund Medical AB
- Medtronic PLC
- QlRad, Inc.
- QFIX
- Boston Scientific Corp.
- Nanovi A/S
- Eckert & Ziegler
- IBA Dosimetry GmbH
Recent Developments in the Market:
- In March 2020, the liquid fiducial marker from Nanovi A/BioXmark S has achieved CE approval. Over the anticipated time, these changes are projected to increase the market in Germany.
Global Fiducial Markers Market Report Scope:
- Historical Data: 2020 - 2021
- Base Year for Estimation: 2022
- Forecast period: 2023-2030
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Product, Modality, Cancer type, End User, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
- Metal Based Markers
- Polymer Based Markers
- Other Fiducial Markers
By Modality:
- CT/CBCT
- MRI
- Radiotherapy
- Ultrasound
By Cancer type:
- Lung Cancer
- Breast Cancer
- Gastric Cancer
- Prostate Cancer
- Other Cancers
By End User:
- Hospitals and Outpatient Facilities
- Cancer Research Centers
- Independent Radiotherapy Centers
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Fiducial Markers Market, by region, 2020-2030 (USD Billion)
- 1.2.2. Fiducial Markers Market, by Product, 2020-2030 (USD Billion)
- 1.2.3. Fiducial Markers Market, by Modality, 2020-2030 (USD Billion)
- 1.2.4. Fiducial Markers Market, by Cancer type, 2020-2030 (USD Billion)
- 1.2.5. Fiducial Markers Market, by End User, 2020-2030 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Fiducial Markers Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Fiducial Markers Market Dynamics
- 3.1. Fiducial Markers Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
- 3.1.1.1. Rising prevalence of cancer
- 3.1.1.2. Growing adoption of radiotherapy treatment
- 3.1.2. Market Challenges
- 3.1.2.1. High Cost of Fiducial Markers
- 3.1.3. Market Opportunities
- 3.1.3.1. Upsurge in the investments and spending for the cancer research
Chapter 4. Global Fiducial Markers Market: Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Porter's 5 Force Impact Analysis
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. COVID-19 Impact Analysis
- 4.7. Disruptive Trends
- 4.8. Industry Expert Perspective
- 4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Fiducial Markers Market, by Product
- 5.1. Market Snapshot
- 5.2. Global Fiducial Markers Market by Product, Performance - Potential Analysis
- 5.3. Global Fiducial Markers Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
- 5.4. Fiducial Markers Market, Sub Segment Analysis
- 5.4.1. Metal Based Markers
- 5.4.2. Polymer Based Markers
- 5.4.3. Other Fiducial Markers
Chapter 6. Global Fiducial Markers Market, by Modality
- 6.1. Market Snapshot
- 6.2. Global Fiducial Markers Market by Modality, Performance - Potential Analysis
- 6.3. Global Fiducial Markers Market Estimates & Forecasts by Modality 2020-2030 (USD Billion)
- 6.4. Fiducial Markers Market, Sub Segment Analysis
- 6.4.1. CT/CBCT
- 6.4.2. MRI
- 6.4.3. Radiotherapy
- 6.4.4. Ultrasound
Chapter 7. Global Fiducial Markers Market, by Cancer type
- 7.1. Market Snapshot
- 7.2. Global Fiducial Markers Market by Cancer type, Performance - Potential Analysis
- 7.3. Global Fiducial Markers Market Estimates & Forecasts by Cancer type 2020-2030 (USD Billion)
- 7.4. Fiducial Markers Market, Sub Segment Analysis
- 7.4.1. Lung Cancer
- 7.4.2. Breast Cancer
- 7.4.3. Gastric Cancer
- 7.4.4. Prostate Cancer
- 7.4.5. Other Cancers
Chapter 8. Global Fiducial Markers Market, by End User
- 8.1. Market Snapshot
- 8.2. Global Fiducial Markers Market by End User, Performance - Potential Analysis
- 8.3. Global Fiducial Markers Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
- 8.4. Fiducial Markers Market, Sub Segment Analysis
- 8.4.1. Hospitals and Outpatient Facilities
- 8.4.2. Cancer Research Centers
- 8.4.3. Independent Radiotherapy Centers
Chapter 9. Global Fiducial Markers Market, Regional Analysis
- 9.1. Top Leading Countries
- 9.2. Top Emerging Countries
- 9.3. Fiducial Markers Market, Regional Market Snapshot
- 9.4. North America Fiducial Markers Market
- 9.4.1. U.S. Fiducial Markers Market
- 9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
- 9.4.1.2. Modality breakdown estimates & forecasts, 2020-2030
- 9.4.1.3. Cancer type breakdown estimates & forecasts, 2020-2030
- 9.4.1.4. End User breakdown estimates & forecasts, 2020-2030
- 9.4.2. Canada Fiducial Markers Market
- 9.5. Europe Fiducial Markers Market Snapshot
- 9.5.1. U.K. Fiducial Markers Market
- 9.5.2. Germany Fiducial Markers Market
- 9.5.3. France Fiducial Markers Market
- 9.5.4. Spain Fiducial Markers Market
- 9.5.5. Italy Fiducial Markers Market
- 9.5.6. Rest of Europe Fiducial Markers Market
- 9.6. Asia-Pacific Fiducial Markers Market Snapshot
- 9.6.1. China Fiducial Markers Market
- 9.6.2. India Fiducial Markers Market
- 9.6.3. Japan Fiducial Markers Market
- 9.6.4. Australia Fiducial Markers Market
- 9.6.5. South Korea Fiducial Markers Market
- 9.6.6. Rest of Asia Pacific Fiducial Markers Market
- 9.7. Latin America Fiducial Markers Market Snapshot
- 9.7.1. Brazil Fiducial Markers Market
- 9.7.2. Mexico Fiducial Markers Market
- 9.8. Middle East & Africa Fiducial Markers Market
- 9.8.1. Saudi Arabia Fiducial Markers Market
- 9.8.2. South Africa Fiducial Markers Market
- 9.8.3. Rest of Middle East & Africa Fiducial Markers Market
Chapter 10. Competitive Intelligence
- 10.1. Key Company SWOT Analysis
- 10.1.1. Company 1
- 10.1.2. Company 2
- 10.1.3. Company 3
- 10.2. Top Market Strategies
- 10.3. Company Profiles
- 10.3.1. CIVCO Radiotherapy
- 10.3.1.1. Key Information
- 10.3.1.2. Overview
- 10.3.1.3. Financial (Subject to Data Availability)
- 10.3.1.4. Product Summary
- 10.3.1.5. Recent Developments
- 10.3.2. IZI Medical Products
- 10.3.3. Naslund Medical AB
- 10.3.4. Medtronic PLC
- 10.3.5. QlRad, Inc.
- 10.3.6. QFIX
- 10.3.7. Boston Scientific Corp.
- 10.3.8. Nanovi A/S
- 10.3.9. Eckert & Ziegler
- 10.3.10. IBA Dosimetry GmbH
Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
- 11.3. Research Assumption
°ü·ÃÀÚ·á